Xetra
30.10.25 | 12:44
1,135 Euro
-1,13 % -0,013
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,131 | 1,133 | 17:38 | |
| 1,125 | 1,139 | 17:39 |
► 30.10.: | | | | | | | | |
17:30
► 29.10.: | | | | | | | | |
► Aktueller PHARMING Börsenkurs + Xetra-Orderbuch
► 29.10.: | | | | | | | | |
► Aktueller PHARMING Börsenkurs + Xetra-Orderbuch
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 1,168 | 17.418 | |||
| 1,150 | 30.000 | |||
| 1,149 | 7.508 | |||
| 1,145 | 17.418 | |||
| 1,144 | 7.508 | |||
| 1,136 | 7.392 | |||
| 1,135 | 24.900 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/phgn.htm [/URL] | ||||
| 7.392 | 1,130 | |||
| 17.392 | 1,129 | |||
| 17.508 | 1,128 | |||
| 7.508 | 1,127 | |||
| 47.508 | 1,126 | |||
| 7.508 | 1,125 | |||
| 7.508 | 1,124 | |||
| 30.000 | 1,120 | |||
| 17.418 | 1,119 | |||
| 17.418 | 1,096 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 177.160 | 0,633 | 112.144 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 12:44:42 | 1,135 | 408 |
| Tagesumsatz Xetra | -0,013 -1,13 % | 23.523 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08:10 | Pharming Group N.V.: Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London | 184 | GlobeNewswire (Europe) | Leiden, the Netherlands, October 30, 2025: Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the Jefferies Global Healthcare... ► Artikel lesen | |
| PHARMING Aktie jetzt für 0€ handeln | |||||
| 23.10. | Pharming Group N.V.: Pharming Group to report third quarter 2025 financial results and provide business update on November 6 | 232 | GlobeNewswire (Europe) | Leiden, the Netherlands, October 23, 2025: Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the... ► Artikel lesen | |
| 22.10. | Pharming Group N.V. - 6-K, Report of foreign issuer | 6 | SEC Filings | ||
| 20.10. | Pharming Group N.V.: Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio | 5 | GlobeNewswire (USA) | ||
| 06.10. | Pharming Group N.V.: Pharming Group provides update on previously announced G&A expense reduction plan | 179 | GlobeNewswire (Europe) | Leiden, the Netherlands, October 6, 2025: Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM; Nasdaq: PHAR) today announced the implementation of an organizational restructuring to... ► Artikel lesen |
1 2 3 4 5 Weiter >>
47 Nachrichten in den letzten 12 Monaten
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 15:21 | Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc | Dow Jones News | DJ Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
The Vanguard Group, Inc. (IRSH)
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc
30-Oct-2025 / 13:45 GMT/BST
=----------------------------------------------------------------------------------------------------------------------... ► Artikel lesen | |
| 14:38 | Lunai Bioworks Inc.: Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds | ACCESS Newswire | NEW YORK, NY / ACCESS Newswire / October 30, 2025 / In the face of growing global concern over the potential use of chemical weapons such as the nerve agent Sarin, Lunai Bioworks Inc. (NASDAQ:LNAI)... ► Artikel lesen | |
| 15:48 | Abeona Therapeutics Inc.: Abeona Therapeutics Announces Permanent J-Code for ZEVASKYN (prademagene zamikeracel) | GlobeNewswire (Europe) | CLEVELAND, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced... ► Artikel lesen | |
| 14:26 | Dogwood Therapeutics, Inc.: Dogwood Therapeutics to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025 | ACCESS Newswire | ATLANTA, GA / ACCESS Newswire / October 30, 2025 / Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company developing new medicines to treat pain and neuropathy... ► Artikel lesen | |
| 16:38 | Hemostemix Inc.: Hemostemix's Boots on the Ground in Florida October Update | Newsfile | Calgary, Alberta--(Newsfile Corp. - October 30, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell (ACP-01)... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMING GROUP NV finden Sie auf Wallstreet Online.